UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Study the effects of PLGA-PEG encapsulated Amphotericin B nanoparticle drug delivery system against Leishmania donovani

Drug delivery, 2015-05, Vol.22 (3), p.383-388

2015

Volltextzugriff (PDF)

Mining the Proteome of Leishmania donovani for the Development of Novel MHC Class I Restricted Epitope for the Control of Visceral Leishmaniasis

Journal of cellular biochemistry, 2018-01, Vol.119 (1), p.378-391

2018

Volltextzugriff (PDF)

Oral miltefosine for Indian post‐kala‐azar dermal leishmaniasis: a randomised trial

Tropical medicine & international health, 2013-01, Vol.18 (1), p.96-100

2013

Volltextzugriff (PDF)

Safety and efficacy of a combination of paromomycin and miltefosine for two vs. three courses in patients with post‐kala‐azar dermal leishmaniasis: an observational pilot study

British journal of dermatology (1951), 2017-08, Vol.177 (2), p.557-559

2017

Volltextzugriff (PDF)

Asymptomatic infection of visceral leishmaniasis in hyperendemic areas of Vaishali district, Bihar, India: a challenge to kala-azar elimination programmes

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2011-11, Vol.105 (11), p.661-666

2011

Volltextzugriff (PDF)

Up regulation of A sub(2B) adenosine receptor on monocytes are crucially required for immune pathogenicity in Indian patients exposed to Leishmania donovani

Cytokine (Philadelphia, Pa.), 2016-03, Vol.79, p.38-44

2016

Volltextzugriff (PDF)

Evaluation of Cholinesterase Level in an Endemic Population Exposed to Malathion Suspension Formulation as a Vector Control Measure

Memórias do Instituto Oswaldo Cruz, 2004-03, Vol.99 (2), p.219-221

2004

Volltextzugriff (PDF)

Designing Therapies against Experimental Visceral Leishmaniasis by Modulating the Membrane Fluidity of Antigen-Presenting Cells

Infection and Immunity, 2009-06, Vol.77 (6), p.2330-2342

2009

Volltextzugriff (PDF)

Development of high efficacy peptide coated iron oxide nanoparticles encapsulated amphotericin B drug delivery system against visceral leishmaniasis

Materials Science & Engineering C, 2017-06, Vol.75, p.1465-1471

2017

Volltextzugriff (PDF)

Fatal acute pancreatitis in a patient with visceral leishmaniasis during miltefosine treatment

Journal of postgraduate medicine, 2013-10, Vol.59 (4), p.306-308

2013

Volltextzugriff (PDF)

Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection

Experimental parasitology, 2012-07, Vol.131 (3), p.274-282

2012

Volltextzugriff (PDF)

Clinical epidemiologic profile of a cohort of post-kala-azar dermal leishmaniasis patients in Bihar, India

The American journal of tropical medicine and hygiene, 2012-06, Vol.86 (6), p.959-961

2012

Volltextzugriff (PDF)

Development of post-kala-azar dermal leishmaniasis in AmBisome treated visceral leishmaniasis: A possible challenge to elimination program in India

Journal of postgraduate medicine, 2013-07, Vol.59 (3), p.226-228

2013

Volltextzugriff (PDF)

AWARENESS ABOUT KALA-AZAR DISEASE AND RELATED PREVENTIVE ATTITUDES AND PRACTICES IN A HIGHLY ENDEMIC RURAL AREA OF INDIA

Southeast Asian journal of tropical medicine and public health, 2010, Vol.41 (1), p.1-12

2010

Volltextzugriff (PDF)

Development of Post–Kala-Azar Dermal Leishmaniasis (PKDL) in Miltefosine-Treated Visceral Leishmaniasis

The American journal of tropical medicine and hygiene, 2009-03, Vol.80 (3), p.336-338

2009

Volltextzugriff (PDF)

Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar

The National medical journal of India, 2005-05, Vol.18 (3), p.131

2005

Volltextzugriff (PDF)

Visceral leishmaniasis (kala-azar)—the Bihar (India) perspective

The Journal of infection, 2006-07, Vol.53 (1), p.60-64

2006

Volltextzugriff (PDF)

Wilson disease with visceral leishmaniasis: an extremely uncommon presentation

The American journal of tropical medicine and hygiene, 2007-09, Vol.77 (3), p.560-561

2007

Volltextzugriff (PDF)

Leishmania donovani: Effect of therapy on expression of CD2 antigen and secretion of macrophage migration inhibition factor by T-cells in patients with visceral leishmaniasis

Experimental parasitology, 2005-10, Vol.111 (2), p.130-132

2005

Volltextzugriff (PDF)

Leishmania donovani in blood smears of asymptomatic persons

Acta tropica, 2000-09, Vol.76 (2), p.195-196

2000

Volltextzugriff (PDF)

Nanotechnology: A promising approach of antiviral treatments against chikungunya virus (CHIKV)

Journal of Scientific and Innovative Research, 2018-06, Vol.7 (2), p.55-59

2018

Volltextzugriff (PDF)

Effects of core iron oxide nanoparticles on microbial control and bacteriostatic activity against Escherichia coli, Staphylococcus aureus and Mycobacterium smegmatis

Journal of Scientific and Innovative Research, 2014-10, Vol.3 (5), p.495-498

2014

Volltextzugriff (PDF)

Visceral leishmaniasis in pregnancy - the role of amphotericin B

Annals of tropical medicine and parasitology, 2008-04, Vol.102 (3), p.267-270

2008

Volltextzugriff (PDF)

Usefulness of the direct agglutination test in the early detection of subclinical Leishmania donovani infection: a community-based study

Annals of tropical medicine and parasitology, 2005-12, Vol.99 (8), p.743-749

2005

Volltextzugriff (PDF)

HIV-1 infection, visceral leishmaniasis, Koch's chest and tuberculous meningitis in the same patient - a case report

Annals of tropical medicine and parasitology, 2005-12, Vol.99 (8), p.807-811

2005

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(21)
Humans
(20)
Leishmaniasis, Visceral - Drug Therapy
(14)
Male
(13)
Female
(12)
Adult
(11)
Animals
(11)
Parasitic Diseases
(11)
Biological And Medical Sciences
(10)
Infectious Diseases
(10)
Leishmania Donovani
(10)
Adolescent
(9)
Human Protozoal Diseases
(9)
Leshmaniasis
(9)
Medical Sciences
(9)
Protozoal Diseases
(9)
Tropical Medicine
(9)
Visceral Leishmaniasis
(9)
Antiprotozoal Agents - Therapeutic Use
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Study the effects of PLGA-PEG encapsulated Amphotericin B nanoparticle drug delivery system against Leishmania donovani

Mining the Proteome of Leishmania donovani for the Development of Novel MHC Class I Restricted Epitope for the Control of Visceral Leishmaniasis

Oral miltefosine for Indian post‐kala‐azar dermal leishmaniasis: a randomised trial

Safety and efficacy of a combination of paromomycin and miltefosine for two vs. three courses in patients with post‐kala‐azar dermal leishmaniasis: an observational pilot study

Asymptomatic infection of visceral leishmaniasis in hyperendemic areas of Vaishali district, Bihar, India: a challenge to kala-azar elimination programmes

Up regulation of A sub(2B) adenosine receptor on monocytes are crucially required for immune pathogenicity in Indian patients exposed to Leishmania donovani

Evaluation of Cholinesterase Level in an Endemic Population Exposed to Malathion Suspension Formulation as a Vector Control Measure

Designing Therapies against Experimental Visceral Leishmaniasis by Modulating the Membrane Fluidity of Antigen-Presenting Cells

Development of high efficacy peptide coated iron oxide nanoparticles encapsulated amphotericin B drug delivery system against visceral leishmaniasis

Fatal acute pancreatitis in a patient with visceral leishmaniasis during miltefosine treatment

Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection

Clinical epidemiologic profile of a cohort of post-kala-azar dermal leishmaniasis patients in Bihar, India

Development of post-kala-azar dermal leishmaniasis in AmBisome treated visceral leishmaniasis: A possible challenge to elimination program in India

AWARENESS ABOUT KALA-AZAR DISEASE AND RELATED PREVENTIVE ATTITUDES AND PRACTICES IN A HIGHLY ENDEMIC RURAL AREA OF INDIA

Development of Post–Kala-Azar Dermal Leishmaniasis (PKDL) in Miltefosine-Treated Visceral Leishmaniasis

Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar

Visceral leishmaniasis (kala-azar)—the Bihar (India) perspective

Wilson disease with visceral leishmaniasis: an extremely uncommon presentation

Leishmania donovani: Effect of therapy on expression of CD2 antigen and secretion of macrophage migration inhibition factor by T-cells in patients with visceral leishmaniasis

Leishmania donovani in blood smears of asymptomatic persons

Nanotechnology: A promising approach of antiviral treatments against chikungunya virus (CHIKV)

Effects of core iron oxide nanoparticles on microbial control and bacteriostatic activity against Escherichia coli, Staphylococcus aureus and Mycobacterium smegmatis

Visceral leishmaniasis in pregnancy - the role of amphotericin B

Usefulness of the direct agglutination test in the early detection of subclinical Leishmania donovani infection: a community-based study

HIV-1 infection, visceral leishmaniasis, Koch's chest and tuberculous meningitis in the same patient - a case report

Suchergebnisse filtern